Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study.

Lambert, Robert G W   •   Salonen, David   •   Rahman, Proton   •   Inman, Robert D   •   Wong, Robert L   •   Einstein, Steven G   •   Thomson, Glen T D   •   Beaulieu, Andre   •   Choquette, Denis   •   Maksymowych, Walter P

published in: Arthritis and rheumatism



endpoint

Etanercept has (optional: compared with placebo) proved to be better.
general condition better


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection
conservative therapy → injection therapy

publication details

10.1002/art.23044
pubmed
18050198
2007
Journal Article
randomized controlled trial
yes
prospective
1+